Figure 1.
Potential mechanisms for improved left ventricular diastolic function and reduced left ventricular mass with sodium‐glucose cotransporter 2 inhibitors. LV, left ventricular; SGLT2, sodium‐glucose cotransporter 2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.